KorrekturOpen Access · CC BY 4.0
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”
Advanced Science · 2026-06 · 13 (33)
DOI: 10.1002/advs.75571 ↗Kurz gefasst
Korrektur in der Zeitschrift Advanced Science, online erschienen am 07.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571
Vancouver
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571
BibTeX
@article{euvimed2026,
title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {33},
doi = {10.1002/advs.75571}
}
EUVIMED